BeWell Buddy is looking for contributors:

Would you like to post an article or write a review? Contact Us Here.

Mental Health

Researchers Discover Novel Therapeutic For Chronic Pain

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Columbia scientists working to combat injury-related depression, substance abuse and suicide due to unremitting, persistent pain may have discovered a new way of treating that pain: a powerful analgesic dubbed N60 that leads to neither tolerance nor addiction. Pain is a perception in the brain triggered by signals sent along nerves in the peripheral nervous [...] Read more »

  • Share/Bookmark


Suicide Attempts Constitute A Significant Portion Of Drug-Related Hospital Emergency Department Visits — Especially Among The Young

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

A new series of studies analyzing drug-related hospital emergency department visits throughout the country during 2008 reveals a substantial percentage of these visits involve suicide attempts. According to these studies conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) more than one in every twelve (8…

Read The Full Article…Suicide Attempts Constitute A Significant [...] Read more »

  • Share/Bookmark


Closer To A Treatment For Autism

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Rubicon winner Dalila Pinto discovered a copying error in the DNA of trial subjects who suffered from autism or a similar condition. Some segments of their DNA were copied either once too often or missed out of the copying process. This is a highly promising result from the world’s largest investigation into autism. The top [...] Read more »

  • Share/Bookmark


Shedding Light On How Psychiatric Risk Gene Disrupts Brain Development

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Scientists are making progress towards a better understanding of the neuropathology associated with debilitating psychiatric illnesses like bipolar disorder and schizophrenia. New research, published by Cell Press in the July 15 issue of the journal Neuron, reveals mechanisms that connect a known psychiatric risk gene to disruptions in brain cell proliferation and migration during development…

Read [...] Read more »

  • Share/Bookmark


PTSD Treatment Claims Process Eased, Some Remain Skeptical

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

NPR: The Department of Veterans Affairs announced a new rule Monday that aims to make it easier for troops who return from battle to get the PTSD support they need. “Veterans will no longer have to prove that a certain attack, bomb explosion or event in a combat zone triggered post-traumatic stress. It’s a change [...] Read more »

  • Share/Bookmark


VA To Ease Rules For Vets To Qualify For PTSD Benefits

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Today, The Department of Veterans Affairs is scheduled to announce it will ease requirements for service members to qualify for post traumatic stress disorder benefits. The change was announced Saturday by President Barack Obama in his weekly address…

Read The Full Article…VA To Ease Rules For Vets To Qualify For PTSD Benefits Read more »

  • Share/Bookmark


Supernus Pharmaceuticals Advances SPN812 Into Phase IIa U.S. Clinical Trial For ADHD

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Supernus Pharmaceuticals, Inc. announced the initiation of a Phase IIa U.S. clinical trial of its product candidate SPN812 for the treatment of ADHD in adults. The trial is a proof-of-concept, randomized, double-blind, placebo-controlled study in healthy adults aged 18 to 64, inclusive, with ADHD. Supernus expects to enroll 50 subjects in the study at 5 [...] Read more »

  • Share/Bookmark


FDA Approves Daytrana® (methylphenidate Transdermal System) CII For The Treatment Of ADHD In Adolescents

Jul 16th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years…

Read The Full Article…FDA Approves Daytrana® (methylphenidate Transdermal System) CII For The Treatment Of [...] Read more »

  • Share/Bookmark


New Look NHS Must Deliver On Mental Health, UK

Jul 13th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

The Government has outlined proposals to overhaul the structure of the NHS including transferring the responsibility for commissioning to GPs (1). Commenting on the changes, Mind’s Chief Executive Paul Farmer said: The litmus test of the new look NHS will be whether it meets the needs of people with mental health problems…

Read The Full [...] Read more »

  • Share/Bookmark


Secretary Sebelius Visits Grand Isle Beach And New Orleans To Assess Health Impact Of Gulf Oil Spill

Jul 13th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental Health

Health and Human Services Secretary Kathleen Sebelius visited Grand Isle Beach and New Orleans, Louisiana as part the Department’s ongoing efforts to to address the public health and mental health aspects of the Gulf oil spill. She was joined by HHS officials Dr. James Galloway, health liaison to the National Incident Command, and Dr…

Read The [...] Read more »

  • Share/Bookmark